ML329 is a micropthalmia-associated transcription factor ( MITF ) inhibitor, which inhibits TRPM-1 promoter activity with an IC 50 of 1.2 μM.
Products | Products > Disease Areas > Others | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Others | Products > Signaling Pathways > Microphthalmia Associated Transcription Factor (MITF)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.